General Oncology section

General Oncology News & Features

Median Cost of Cancer Drug Development is Approximately $648 Million

Median Cost of Cancer Drug Development is Approximately $648 Million

Total revenue from sales of 10 drugs was 67.0 billion, with total RD spending of 7.2 billion, researchers found.

Cannabis Reduces Response Rate to Immunotherapy for Cancer

Cannabis Reduces Response Rate to Immunotherapy for Cancer

Investigators report that administering cannabis to patients with cancer undergoing immunotherapy was found to lower the response rate to therapy but had no effect on PFS or OS, in an oral presentation at ESMO 2017 Congress.

Prevalence of Aggressive Cancer Care at End of Life Remains Unchanged

Prevalence of Aggressive Cancer Care at End of Life Remains Unchanged

Researchers reported trends of aggressiveness of cancer care near the end of life (ACCEoL) have remained unchanged in adult patients despite increasing resources for integrated palliative care in a presentation at ESMO 2017 Congress.

Impact of Distress on Adherence to Cancer Screening Recommendations

Impact of Distress on Adherence to Cancer Screening Recommendations

Most studies focus on false-positive results and follow-ups. In this study, researchers sought to determine distress levels at the time of screening and its potential impact on adherence to screening recommendations.

Breakthrough Cancer Pain Managed Effectively With Fentanyl Buccal Tablets

Breakthrough Cancer Pain Managed Effectively With Fentanyl Buccal Tablets

This prospective, noninterventional trial evaluated the response of 276 patients to FBT from 64 pain and oncology clinics

Cause of Superior Vena Cava Syndrome in Cancer Determines Prognosis

Cause of Superior Vena Cava Syndrome in Cancer Determines Prognosis

Prognosis for cancer patients with superior vena cava syndrome is highly associated with the underlying cause of the syndrome.

Hyponatremia May Lead to Worse Symptom Severity, Frequency in Cancer

Hyponatremia May Lead to Worse Symptom Severity, Frequency in Cancer

Patients with cancer who develop hyponatremia suffer from more symptoms with greater severity than normonatremic patients; however, no significant association was found between in-hospital mortality or length of hospital stay and hyponatremia.

Affect of Daratumumab on Laboratory Blood Test Results

Affect of Daratumumab on Laboratory Blood Test Results

Do monoclonal antibodies other than daratumumab cause false positives in the blood antibody screen and crossmatch obtained prior to a transfusion?

Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes

Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes

As the use of checkpoint inhibitors increases in many types of cancer, oncology nurses need to learn to recognize the signs and symptoms of pneumonitis, a rare but life-threatening adverse effect of these agents.

Risk of Some Cancers Higher in Women With a History of Periodontal Disease

Risk of Some Cancers Higher in Women With a History of Periodontal Disease

A study on a cohort of women enrolled in the WHI-OS shows that those with a history of periodontal disease had a higher risk for developing some cancers.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs